HFR A-equilibrium on Cardiovascular Stability (AIMS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Aim of the present randomized controlled multinational trial is the comparison of a novel biofeedback system on sodium profiling applied to a endogenous hemodiafiltration therapy, with the standard (no sodium profiling) hemodiafiltration technique on the intradialytic overall and cardiovascular stability.
| Condition | Intervention | Phase |
|---|---|---|
|
Hypotension |
Device: Automated sodium profiling in endogenous hemodiafiltration Device: Standard sodium dialysate |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Randomized Controlled Study on the Effect of the Hemodiafiltration Plasma Sodium Biofeedback System on Cardiovascular Stability in Hemodialysis Patients |
- Number of dialysis complicated by at least one hypotension [ Time Frame: six months ] [ Designated as safety issue: No ]
Hypotension definition:
If predialysis systolic blood pressure greater than100 mmHg then a value during dialysis below 90 mmHg or any systolic blood pressure reduction greater than 25 mmHg in presence of symptoms or If predialysis systolic blood pressure less than 90 mmHg a reduction of at least 10% accompanied by symptoms
- Blood Pressure Intradialytic symptoms [ Time Frame: six months ] [ Designated as safety issue: No ]Systolic, diastolic blood pressures (SBP, DBP) and heart rate (HR) measured at the beginning of each treatment and every 30 minutes till the end of dialysis; intradialytic symptoms (nausea, vomiting, hypotension, headache, cramps) and related clinical interventions.
| Enrollment: | 50 |
| Study Start Date: | April 2007 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Standard
Standard constant (no profiled) sodium dialysate used during endogenous hemodiafiltration
|
Device: Standard sodium dialysate
Standard constant (no profiled) sodium dialysate used during endogenous hemodiafiltration
Other Name: Standard HFR
|
|
Experimental: Automated profiled
Automate sodium profiling in endogenous hemodiafiltration
|
Device: Automated sodium profiling in endogenous hemodiafiltration
Automated sodium profiling during endogenous reinfusion hemodiafiltration technique. The device processes the dialysate sodium and ultrafiltration rate during dialysis to achieve a preset sodium target at the end of the treatment. Sodium dialysate and maximal ultrafiltration rate are constraint within safety limits during dialysis.
Other Name: HFR-Aequilibrium
|
Detailed Description:
Online hemodiafiltration (OL-HDF) has been recently associated with better patient survival in comparison with standard hemodialysis in some large observational studies (Canaud et al, KI, 2006; Vilar et al, CJASN , 2009) supporting the hypothesis that convection can improve patients outcomes. Moreover, it has been demonstrated in randomized controlled trials (Locatelli et al, Journal American Society of Nephrology, 2010) that OL-HDF significantly reduced the frequency of intradialytic hypotension. Nonetheless, the associated comorbidities and ageing of dialysis population require further devices able to improve treatment tolerance. Among these tools, the sodium profiling and biofeedback system seem to be promising to accomplish this task. But the correct intradialytic sodium balance is still far away today to be easily achieved. The use of an automated adaptive system dialysis to the sodium profiling has been investigated in a feasibility trial (Colì et al International Journal Artificial Organs, 2003). They also investigated the impact of such a device on treatment tolerance.
The aim of this randomized multinational multicenter controlled trial is to evaluate the impact of sodium profiling applied to a endogenous hemodiafiltration technique on the intradialytic cardiovascular stability in comparison to standard no profiled endogenous hemodiafiltration.
Eligibility| Ages Eligible for Study: | 18 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with more than 30% of dialysis complicated by hypotension
- age between 18 and 85 yers
- time on dialysis greater than 6 months
- residual creatinine clearance less than 2 ml/min/1.73 m2
- native fistula or central venous catheter with blood flow rate greater than 250 ml/min
Exclusion Criteria:
- Life expectancy less than 1 year
- solid active neoplasm
- pregnancy
- major event in the previous 3 months (ictus, myocardial infarction, cachexia)
Contacts and Locations| Belgium | |
| Hospital Erasme | |
| Bruxelles, Belgium | |
| France | |
| Dept. of Nephrology and Dialysis Centre Pasteur Vallery Radat | |
| Paris, France | |
| Civil Hospital Bretagne Atlantique | |
| Vannes, France | |
| Germany | |
| Clinic of Internal Medicine | |
| Rostock, Germany | |
| Italy | |
| Nephrology and Dialysis Unit Ospedali Riuniti | |
| Ancona, Italy | |
| UO Nefrologia Dialisi e Trapianto Policlinico S. Orsola Malpighi | |
| Bologna, Italy, 40128 | |
| Civil Hospital | |
| Ciriè, Italy | |
| PO Lastaria | |
| Foggia, Italy | |
| Hospital Maggiore della Carità | |
| Novara, Italy | |
| Casa Sollievo della Sofferenza | |
| San Giovanni Rotondo, Italy | |
| Ospedale San Giovanni Bosco | |
| Torino, Italy | |
| Spain | |
| Hospital Val d'Hebron | |
| Barcellona, Spain | |
| Study Chair: | Francesco Locatelli, Prof. | Azienda Ospedaliera di Lecco |
More Information
No publications provided
| Responsible Party: | Francesco Locatelli, Prof., Azienda Ospedaliera di Lecco |
| ClinicalTrials.gov Identifier: | NCT01414842 History of Changes |
| Other Study ID Numbers: | HFR-AE-2006, HFR-BFBCK0611 |
| Study First Received: | August 10, 2011 |
| Last Updated: | August 26, 2011 |
| Health Authority: | Italy: Ministry of Health |
Additional relevant MeSH terms:
|
Hypotension Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on June 18, 2013